MANIFOLD
Will a drug company pay >$1m in a class action suit based on their statements about their GLP1 inhibitor by 2026?
5
Ṁ100Ṁ185
resolved Jan 7
Resolved
NO

This category of drug is finding more and more uses for a variety of conditions, but the history of drugs, and weight loss drugs in particular, is legally fraught (Phen-Fen, etc.) Are we irrationally exuberant about GLP1 or is it different this time?

Market context
Get
Ṁ1,000
to start trading!

🏅 Top traders

#TraderTotal profit
1Ṁ30
2Ṁ21
3Ṁ15
4Ṁ6
© Manifold Markets, Inc.TermsPrivacy